KONINKLIJKE PHILIPS NVR- NY (PHG)
US5004723038
We assign a fundamental rating of 4 out of 10 to PHG. PHG was compared to 187 industry peers in the Health Care Equipment & Supplies industry. PHG has a bad profitability rating. Also its financial health evaluation is rather negative. PHG is not valued too expensively and it also shows a decent growth rate.
1. Profitability
1.1 Basic Checks
In the past year PHG was profitable.
PHG had a positive operating cash flow in the past year.
In multiple years PHG reported negative net income over the last 5 years.
PHG had a positive operating cash flow in 4 of the past 5 years.
1.2 Ratios
PHG has a better Return On Assets (-1.43%) than 67.74% of its industry peers.
The Return On Equity of PHG (-3.54%) is better than 68.82% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -1.43% | ||
| ROE | -3.54% | ||
| ROIC | N/A |
ROA(3y)1.3%
ROA(5y)2.5%
ROE(3y)2.33%
ROE(5y)5.25%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
PHG's Operating Margin has declined in the last couple of years.
The Gross Margin of PHG (41.56%) is worse than 66.67% of its industry peers.
In the last couple of years the Gross Margin of PHG has remained more or less at the same level.
The Profit Margin and Operating Margin are not available for PHG so they could not be analyzed.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 41.56% |
OM growth 3Y-40.52%
OM growth 5Y-26.4%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-1.47%
GM growth 5Y-1.32%
2. Health
2.1 Basic Checks
PHG does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for PHG has been reduced compared to 1 year ago.
PHG has more shares outstanding than it did 5 years ago.
Compared to 1 year ago, PHG has a worse debt to assets ratio.
2.2 Solvency
Based on the Altman-Z score of 1.59, we must say that PHG is in the distress zone and has some risk of bankruptcy.
PHG has a Altman-Z score (1.59) which is in line with its industry peers.
The Debt to FCF ratio of PHG is 7.27, which is on the high side as it means it would take PHG, 7.27 years of fcf income to pay off all of its debts.
Looking at the Debt to FCF ratio, with a value of 7.27, PHG is in the better half of the industry, outperforming 73.12% of the companies in the same industry.
PHG has a Debt/Equity ratio of 0.60. This is a neutral value indicating PHG is somewhat dependend on debt financing.
PHG has a Debt to Equity ratio of 0.60. This is in the lower half of the industry: PHG underperforms 65.59% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.6 | ||
| Debt/FCF | 7.27 | ||
| Altman-Z | 1.59 |
ROIC/WACCN/A
WACC6.12%
2.3 Liquidity
A Current Ratio of 1.16 indicates that PHG should not have too much problems paying its short term obligations.
Looking at the Current ratio, with a value of 1.16, PHG is doing worse than 89.25% of the companies in the same industry.
PHG has a Quick Ratio of 1.16. This is a bad value and indicates that PHG is not financially healthy enough and could expect problems in meeting its short term obligations.
PHG has a Quick ratio of 0.74. This is amonst the worse of the industry: PHG underperforms 89.78% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.16 | ||
| Quick Ratio | 0.74 |
3. Growth
3.1 Past
The Earnings Per Share has been growing slightly by 3.65% over the past year.
PHG shows a decrease in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -2.67% yearly.
The Revenue has decreased by -2.65% in the past year.
Measured over the past years, PHG shows a small growth in Revenue. The Revenue has been growing by 0.05% on average per year.
EPS 1Y (TTM)3.65%
EPS 3Y-15.7%
EPS 5Y-2.67%
EPS Q2Q%-3.03%
Revenue 1Y (TTM)-2.65%
Revenue growth 3Y1.62%
Revenue growth 5Y0.05%
Sales Q2Q%-2.1%
3.2 Future
The Earnings Per Share is expected to grow by 16.64% on average over the next years. This is quite good.
PHG is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 4.04% yearly.
EPS Next Y20.42%
EPS Next 2Y16.17%
EPS Next 3Y15.06%
EPS Next 5Y16.64%
Revenue Next Year-0.83%
Revenue Next 2Y1.72%
Revenue Next 3Y2.71%
Revenue Next 5Y4.04%
3.3 Evolution
When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
4. Valuation
4.1 Price/Earnings Ratio
PHG is valuated rather expensively with a Price/Earnings ratio of 18.92.
87.63% of the companies in the same industry are more expensive than PHG, based on the Price/Earnings ratio.
PHG is valuated rather cheaply when we compare the Price/Earnings ratio to 27.41, which is the current average of the S&P500 Index.
A Price/Forward Earnings ratio of 14.57 indicates a correct valuation of PHG.
Based on the Price/Forward Earnings ratio, PHG is valued cheaper than 89.78% of the companies in the same industry.
Compared to an average S&P500 Price/Forward Earnings ratio of 23.69, PHG is valued a bit cheaper.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 18.92 | ||
| Fwd PE | 14.57 |
4.2 Price Multiples
70.97% of the companies in the same industry are more expensive than PHG, based on the Enterprise Value to EBITDA ratio.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of PHG indicates a rather cheap valuation: PHG is cheaper than 90.32% of the companies listed in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 20.15 | ||
| EV/EBITDA | 29.37 |
4.3 Compensation for Growth
The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
PHG's earnings are expected to grow with 15.06% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.93
PEG (5Y)N/A
EPS Next 2Y16.17%
EPS Next 3Y15.06%
5. Dividend
5.1 Amount
With a Yearly Dividend Yield of 4.15%, PHG is a good candidate for dividend investing.
In the last 3 months the price of PHG has falen by -22.39%. A price decline artificially increases the dividend yield. It may be a sign investors do not expect the dividend to last.
PHG's Dividend Yield is rather good when compared to the industry average which is at 1.67. PHG pays more dividend than 100.00% of the companies in the same industry.
PHG's Dividend Yield is rather good when compared to the S&P500 average which is at 2.33.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 4.15% |
5.2 History
The dividend of PHG decreases each year by -65.46%.
PHG has paid a dividend for at least 10 years, which is a reliable track record.
Dividend Growth(5Y)-65.46%
Div Incr Years0
Div Non Decr Years0
5.3 Sustainability
The earnings of PHG are negative and hence is the payout ratio. PHG will probably not be able to sustain this dividend level.
DP-0.48%
EPS Next 2Y16.17%
EPS Next 3Y15.06%
KONINKLIJKE PHILIPS NVR- NY
NYSE:PHG (1/3/2025, 8:04:00 PM)
After market: 25.16 0 (0%)25.16
+0.18 (+0.72%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)
Earnings (Next)
Inst Owners47.12%
Inst Owner Change-7.55%
Ins Owners0.06%
Ins Owner ChangeN/A
Market Cap23.65B
Analysts71.85
Price Target30.08 (19.55%)
Short Float %0.22%
Short Ratio2.27
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 4.15% |
Dividend Growth(5Y)-65.46%
DP-0.48%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-10.06%
Min EPS beat(2)-13.15%
Max EPS beat(2)-6.96%
EPS beat(4)1
Avg EPS beat(4)-8.37%
Min EPS beat(4)-25.88%
Max EPS beat(4)12.53%
EPS beat(8)3
Avg EPS beat(8)19.85%
EPS beat(12)3
Avg EPS beat(12)2.62%
EPS beat(16)7
Avg EPS beat(16)5.54%
Revenue beat(2)0
Avg Revenue beat(2)-2.71%
Min Revenue beat(2)-2.95%
Max Revenue beat(2)-2.46%
Revenue beat(4)0
Avg Revenue beat(4)-3.39%
Min Revenue beat(4)-7.41%
Max Revenue beat(4)-0.75%
Revenue beat(8)2
Avg Revenue beat(8)-0.89%
Revenue beat(12)2
Avg Revenue beat(12)-1.44%
Revenue beat(16)2
Avg Revenue beat(16)-3.44%
PT rev (1m)-1.31%
PT rev (3m)-4.49%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-4.47%
EPS NY rev (1m)0%
EPS NY rev (3m)-2.71%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-0.28%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-1.49%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 18.92 | ||
| Fwd PE | 14.57 | ||
| P/S | 1.26 | ||
| P/FCF | 20.15 | ||
| P/OCF | 12.73 | ||
| P/B | 1.93 | ||
| P/tB | N/A | ||
| EV/EBITDA | 29.37 |
EPS(TTM)1.33
EY5.29%
EPS(NY)1.73
Fwd EY6.86%
FCF(TTM)1.25
FCFY4.96%
OCF(TTM)1.98
OCFY7.86%
SpS19.91
BVpS13.05
TBVpS-1.58
PEG (NY)0.93
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -1.43% | ||
| ROE | -3.54% | ||
| ROCE | N/A | ||
| ROIC | N/A | ||
| ROICexc | N/A | ||
| ROICexgc | N/A | ||
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 41.56% | ||
| FCFM | 6.27% |
ROA(3y)1.3%
ROA(5y)2.5%
ROE(3y)2.33%
ROE(5y)5.25%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3Y-40.52%
OM growth 5Y-26.4%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-1.47%
GM growth 5Y-1.32%
F-Score5
Asset Turnover0.62
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.6 | ||
| Debt/FCF | 7.27 | ||
| Debt/EBITDA | 7.18 | ||
| Cap/Depr | 51.64% | ||
| Cap/Sales | 3.66% | ||
| Interest Coverage | N/A | ||
| Cash Conversion | 181.09% | ||
| Profit Quality | N/A | ||
| Current Ratio | 1.16 | ||
| Quick Ratio | 0.74 | ||
| Altman-Z | 1.59 |
F-Score5
WACC6.12%
ROIC/WACCN/A
Cap/Depr(3y)53.02%
Cap/Depr(5y)58.22%
Cap/Sales(3y)4.17%
Cap/Sales(5y)4.65%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)3.65%
EPS 3Y-15.7%
EPS 5Y-2.67%
EPS Q2Q%-3.03%
EPS Next Y20.42%
EPS Next 2Y16.17%
EPS Next 3Y15.06%
EPS Next 5Y16.64%
Revenue 1Y (TTM)-2.65%
Revenue growth 3Y1.62%
Revenue growth 5Y0.05%
Sales Q2Q%-2.1%
Revenue Next Year-0.83%
Revenue Next 2Y1.72%
Revenue Next 3Y2.71%
Revenue Next 5Y4.04%
EBIT growth 1Y20.11%
EBIT growth 3Y-39.56%
EBIT growth 5Y-26.36%
EBIT Next Year69.31%
EBIT Next 3Y25.78%
EBIT Next 5YN/A
FCF growth 1Y-60.7%
FCF growth 3Y-2.55%
FCF growth 5Y0.39%
OCF growth 1Y-51.1%
OCF growth 3Y-5.06%
OCF growth 5Y-1.42%